The scientific community is focused on learning about changes in the pharmaceutical industry. This is your finest chance ever to connect with the biggest group of people. We anticipate having attendees from all over the world, including well-known speakers and distinguished delegates, who will share their valuable presentations and energise the scientific community. Drug Safety 2023 is a two-day conference that provides the opportunity to give presentations, disseminate information, network with prospective scientists, make a splash with novel ideas, and get notoriety and recognition. The conference's standout features include renowned speakers, the newest innovations, and the most modern approaches.Young researchers and students may present their research findings at the conference, which offers a platform to highlight pharmacy research from various scientific backgrounds. The conference's primary goal is to disseminate information on biopharmaceuticals and biotherapeutics. An international conference on biopharmaceuticals and biologic drugs would be the ideal setting for knowledge exchange.

Read on drugsafety.pharmaceuticalconferences.com

WCHEHPHM are thrilled to announce the forthcoming World Congress on Health Economics, Health Policy, and Healthcare Management (WCHEHPHM - 23) scheduled for August 29th, 2023, in Addis Ababa, Ethiopia. This conference is designed as a convergence point for researchers, scientists, academics, policymakers, and industry experts across diverse fields to share their insights and knowledge. Attendees will engage in dynamic discussions, idea exchange, and meaningful networking opportunities. WCHEHPHM - 23 is dedicated to spotlighting cutting-edge innovations, trends, and interdisciplinary discourse, promising an enriching experience for all participants.

Read on www.iirst.com

Presenting the World Congress on Health Economics, Health Policy, and Healthcare Management (WCHEHPHM - 23) in Athens, Greece on August 29th, 2023. This conference unites researchers, policymakers, and industry experts for insightful exchanges and connections. (WCHEHPHM - 23) emphasizes cutting-edge trends, innovations, and interdisciplinary discussions, fostering an exceptional platform for attendees to share insights and establish valuable connections across a spectrum of disciplines.

Read on www.iirst.com

As one of the most fascinating cities in the world, Jerusalem presents a unique combination of ancient history, spiritual sanctity, and colorful cultures in all corners. The city's intricate mosaic of old and new makes Jerusalem the perfect backdrop for providing an extraordinary location for an unforgettable meeting. Jerusalem is a place where the East meets the West. Here, professionals from both sides of the globe come together and convene in captivating plenary sessions discussing the latest ground-breaking discoveries.

The SSIEM 2023 Meeting consists of sessions about new insights in neurometabolism, advances in therapeutic modalities, Mitochondrial Disorders - new findings, new pathways, and more. SSIEM provides you with a wide variety of symposia, workshops, posters, and lectures; find new collaboration opportunities among leaders in patient care, research, nutrition, pharmacy, allied health professionals, and palliative care.

Read on go.evvnt.com

Join peers involved in specialty distribution, patient support services, network design, and compliance to break down silos and strategize efforts to improve patient support and access from manufacturer to patient, provider, and other channel partners.  Hear directly from specialty pharmacies, payers, PBMs, government agencies, health systems, and industry leaders to ensure specialty product success and enhance patient care. This Summit includes tailored content on specialty network design and patient support to customize the learning experience as well as shared content to maximize collaboration and knowledge-sharing.

Read on thinc360.com

The 2nd Oligonucleotides CMC and Analytical Development Summit return this August to Boston. With the unprecedented growth of the oligonucleotides market, reaching $2b by 2027 and with over 250 in the clinical phase of drug development, we now seek to unlock the potential of oligonucleotides beyond rare disease to treat large patient populations for undruggable targets. In the last 12 months alone, there have been a number of advances in the field with Switch Therapeutics advancing their first RNAi technology, Avidity turbocharging their antibody-oligo conjugate and Ansa Biotech successfully synthesizing the world's longest oligonucleotide! Despite this, drug developers still face challenges in manufacturability and lack of concrete regulatory protocols.

Read on oligos-cmc-analytical-development.com

Comprehensive analytical support has been crucial to the global success of mRNA medicines. As drug development timelines become more demanding, accessing novel, optimised, and high-throughput analytical methods is essential to guarantee the approval and commercialisation of safe and effective mRNA therapeutics and vaccines.

The inaugural mRNA Analytical Development Summit Europe is the only industry-dedicated forum to showcase critical expertise and the latest techniques in optimised analytics for leading European biopharma. Taking place in Berlin this August, this meeting highlights the importance of advanced analytical approaches and adherence to regulatory requirements, as the European market continues to capitalise on these strategies.

Join the main industry players as they navigate through their case studies and share their experiences!

Read on mrna-analytical-development-europe.com

Introducing (ICGPH - 23), set for August 29th, 2023, in Darkhan, Mongolia. This conference unites researchers, policymakers, industry experts, fostering discussions, idea exchanges, and connections. (ICGPH - 23) is committed to showcasing the latest innovations, trends, and issues, creating an interdisciplinary platform. Open to all interested in advancements, it offers a professional and informative experience to enrich understanding and broaden perspectives across various fields. Join us for this invaluable event.

Read on www.iirst.com

The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insights back to your team. The content will focus on the "sweet spot" of drug development where potency is most critical - pre-clinical development through to commercialization.

This is the only industry-led event dedicated to covering all challenges associated with potency for gene therapy drug developers specifically. We will unite with 60+ analytical, bioassay, Quality Control, regulatory and CMC experts to bring together content that gives actionable insights by combining both strategic and technical content.

Read on genetherapy-potency-assay.com

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.

This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.   The 8th CAR-TCR Summit is returning to Boston as the industry's trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.  Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.

Read on car-tcr-summit.com